Gene · 29968
Papers1,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel equation synthesis for estimating resting energy expenditure in prostate cancer patients. | BMC Urol | 2025 | 40148813 | PubTator, text mining | PubMed |
| An in vivo screen identifies NAT10 as a master regulator of brain metastasis. | Sci Adv | 2025 | 40138393 | PubTator, text mining | PubMed |
| [Integrative transcriptomics-metabolomics approach to identify metabolic pathways regulated by glutamine synthetase activity]. | Se Pu | 2025 | 40045642 | PubTator, text mining | PubMed |
| De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma. | Cancer Res | 2025 | 40029310 | PubTator, text mining | PubMed |
Utility of 6-aza-2-thiothymine in the synthesis of novel [1,2,4]triazolo[4,3-b][1,2,4]triazin-7-one derivatives: synthesis, structure elucidation, molecular docking and in vitro anti-lung cancer activity. | RSC Adv | 2025 | 40013064 | PubTator, text mining | PubMed |
| Serine starvation suppresses the progression of esophageal cancer by regulating the synthesis of purine nucleotides and NADPH. | Cancer Metab | 2025 | 39948566 | PubTator, text mining | PubMed |
| Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study. | NPJ Breast Cancer | 2025 | 39922815 | PubTator, text mining | PubMed |
| Probing the role of Coniferin and Tetrahydrocurcumin from Traditional Chinese medicine against PSAT1 in early-stage ovarian cancer: An in silico study. | PLoS One | 2025 | 39913473 | PubTator, text mining | PubMed |
| FOXC1-mediated serine metabolism reprogramming enhances colorectal cancer growth and 5-FU resistance under serine restriction. | Cell Commun Signal | 2025 | 39773485 | PubTator, text mining | PubMed |
| PSAT1 promotes the progression of colorectal cancer by regulating Hippo-YAP/TAZ-ID1 axis via AMOT. | Mol Cell Biochem | 2025 | 39739271 | PubTator, text mining | PubMed |
| AdipoRon mitigates liver fibrosis by suppressing serine/glycine biosynthesis through ATF4-dependent glutaminolysis. | Ecotoxicol Environ Saf | 2025 | 39662457 | PubTator, text mining | PubMed |
| Fetal Phenotyping and Whole Exome Sequencing for 12 Egyptian Families With Serine Biosynthesis Defect: Novel Clinical and Allelic Findings With a Founder Effect. | Prenat Diagn | 2025 | 39638571 | PubTator, text mining | PubMed |
| Bioinformatics analysis of PSAT1 loss identifies downstream pathways regulated in EGFR mutant NSCLC and a selective gene signature for predicting the risk of relapse. | Oncol Lett | 2025 | 39512505 | PubTator, text mining | PubMed |
| Tanshinone IIA alleviates pulmonary fibrosis by modulating glutamine metabolic reprogramming based on [U-13C5]-glutamine metabolic flux analysis. | J Adv Res | 2025 | 38697470 | PubTator, text mining | PubMed |
| Exploring potential therapeutic targets for small cell lung cancer based on transcriptomics combined with Mendelian randomization analysis. | Front Immunol | 2024 | 39872525 | PubTator, text mining | PubMed |
| Animal-derived free hydrolysate in animal cell culture: Current research and application advances. | J Tissue Eng | 2024 | 39649943 | PubTator, text mining | PubMed |
| Identification and Validation of Serum Biomarkers to Improve Colorectal Cancer Diagnosis. | Cancer Med | 2024 | 39628390 | PubTator, text mining | PubMed |
| Metabolic Transcriptional Activation in Ulcerative Colitis Identified Through scRNA-seq Analysis. | Genes (Basel) | 2024 | 39596612 | PubTator, text mining | PubMed |
| N6-Methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer. | Mol Ther | 2024 | 39489921 | PubTator, text mining | PubMed |
| Interplay between acetylation and ubiquitination controls PSAT1 protein stability in lung adenocarcinoma. | Commun Biol | 2024 | 39433916 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29968/papers?page=6